{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:37:32Z","timestamp":1794605852679,"version":"4.9.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Vulvovaginal Candidiasis (VVC) is a public health problem, with approximately 30\u201350% of women affected at least once during their lifetime. Recurrent Vulvovaginal Candidiasis (RVVC) is diagnosed following three or four repeated episodes of VVC in a calendar year. This condition poses health concerns with significant impacts on the quality of life of women. This cross-sectional study estimated the prevalence of RVVC and assessed the relationship between feminine\/vaginal washes and other factors on RVVC among Ghanaian women in the Sekondi\/Takoradi Metropolis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>A cross-sectional study was employed to gather data from 304 women. Data were collected using a pretested questionnaire. Bivariate and multivariate analyses, including chi-square\/Fisher\u2019s exact test and logistic regression, were performed using Jamovi (R Core Team 2021) software. Proportions were calculated, and odds ratios and their corresponding 95% confidence intervals were computed with the level of significance set at 0.05.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of RVVC was estimated as 48.4% (95% CI 42.6%, 54.1%). Feminine Vaginal wash use (aOR\u2009=\u20093.86; 95% CI\u2009=\u20092.18, 6.84); age 36\u201345 years (aOR\u2009=\u20090.36; 95% CI\u2009=\u20090.17, 0.76) marital status (aOR\u2009=\u20092.37; 95% CI\u2009=\u20091.17, 4.79) and Sexual activity (aOR:0.43: 95%CI\u2009=\u20090.21, 0.88) were significantly associated with RVVC with <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.005.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>RVVC is prevalent among women in the Sekondi\/Takoradi Metropolis of Ghana. Feminine\/Vaginal washes could be cautiously linked to the development of RVVC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-024-17668-x","type":"journal-article","created":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T12:02:35Z","timestamp":1704456155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Recurrent Vulvovaginal Candidiasis: Assessing the relationship between feminine\/vaginal washes and other factors among Ghanaian women"],"prefix":"10.1186","volume":"24","author":[{"given":"Emmanuel","family":"Otoo-Annan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4360-4747","authenticated-orcid":false,"given":"Vivian Efua","family":"Senoo-Dogbey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,5]]},"reference":[{"issue":"1","key":"17668_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-019-0748-8","volume":"19","author":"J Yano","year":"2019","unstructured":"Yano J, Sobel JD, Nyirjesy P, Sobel R, Williams VL, Yu Q, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019;19(1):1\u20139.","journal-title":"BMC Womens Health"},{"issue":"4","key":"17668_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","volume":"70","author":"KA Workowski","year":"2021","unstructured":"Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Reports. 2021;70(4):1\u2013187.","journal-title":"MMWR Recomm Reports"},{"issue":"1","key":"17668_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1477-7525-11-169","volume":"11","author":"S Aball\u00e9a","year":"2013","unstructured":"Aball\u00e9a S, Guelfucci F, Wagner J, Khemiri A, Dietz JP, Sobel J, et al. Subjective health status and health-related quality of life among women with recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA. Health Qual Life Outcomes. 2013;11(1):1\u201313.","journal-title":"Health Qual Life Outcomes"},{"key":"17668_CR4","doi-asserted-by":"publisher","unstructured":"Jenkins A, Money D, Doherty KCO. Is the vaginal cleansing product industry causing harm to women? Expert Rev Anti Infect Ther [Internet]. 2021;19(3):267\u201370. https:\/\/doi.org\/10.1080\/14787210.2020.1822166.","DOI":"10.1080\/14787210.2020.1822166"},{"key":"17668_CR5","doi-asserted-by":"crossref","unstructured":"Pesewu GA, Feglo PK, Boateng RK, Fayemiwo SA. Prevalence and antifungal susceptibility pattern of candida 1 solates from women with recurrent vulvovaginal candidiasis in Ghana:a review of laboratory reports. Res Square. 2020. p. 1\u201324.","DOI":"10.21203\/rs.3.rs-33278\/v1"},{"issue":"2","key":"17668_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/microorganisms8020144","volume":"8","author":"D Rosati","year":"2020","unstructured":"Rosati D, Bruno M, Jaeger M, Ten Oever J, Netea MG. Recurrent vulvovaginal candidiasis: an immunological perspective. Microorganisms. 2020;8(2):1\u201314.","journal-title":"Microorganisms"},{"issue":"11","key":"17668_CR7","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1016\/S1473-3099(18)30103-8","volume":"18","author":"DW Denning","year":"2018","unstructured":"Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Global burden of recurrent vulvovaginal candidiasis: a systematic review. Lancet Infect Dis. 2018;18(11):e339\u201347.","journal-title":"Lancet Infect Dis"},{"key":"17668_CR8","doi-asserted-by":"crossref","unstructured":"Moshfeghy Z, Tahari S, Janghorban R, Najib FS, Mani A, Sayadi M. Association of sexual function and psychological symptoms including depression, anxiety and stress in women with recurrent vulvovaginal candidiasis. Vol. 21, Journal of the Turkish German Gynecology Association. 2020. p. 90\u20136.","DOI":"10.4274\/jtgga.galenos.2019.2019.0077"},{"issue":"2","key":"17668_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5812\/jjm.10078","volume":"7","author":"S Rasti","year":"2014","unstructured":"Rasti S, Asadi MA, Taghriri A, Behrashi M, Mousavie G. Vaginal candidiasis complications on pregnant women. Jundishapur J Microbiol. 2014;7(2):1\u20132.","journal-title":"Jundishapur J Microbiol"},{"key":"17668_CR10","unstructured":"Polychronis M. The limitations of Ghana\u2019s rural health care access: Case study of GA East, Greater Accra [Internet]. Global Futures: International Policy Network. 2015 [cited 2023 Sep 21]. Available from: efaidnbmnnnibpcajpcglclefindmkaj https:\/\/polisci.rutgers.edu\/publications\/occasional-paper-series\/273-occasional-paper-4-maria-polychronis\/file."},{"key":"17668_CR11","doi-asserted-by":"crossref","unstructured":"Pesewu GA, Feglo PK, Boateng RK, Fayemiwo SA. Prevalence and Antifungal Susceptibility Pattern of Candida isolates from women with recurrent Vulvovaginal Candidiasis in Ghana - A Review of Laboratory Reports. Res Sq. 2020;1\u201324.","DOI":"10.21203\/rs.3.rs-33278\/v1"},{"issue":"2","key":"17668_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jof5020038","volume":"5","author":"BK Ocansey","year":"2019","unstructured":"Ocansey BK, Pesewu GA, Codjoe FS, Osei-Djarbeng S, Feglo PK, Denning DW. Estimated burden of serious fungal infections in Ghana. J Fungi. 2019;5(2):1\u201315.","journal-title":"J Fungi"},{"issue":"1","key":"17668_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12905-019-0720-7","volume":"19","author":"FA Ziba","year":"2019","unstructured":"Ziba FA, Yakong VN, Asore RA, Frederickson K, Flynch M. Douching practices among women in the Bolgatanga municipality of the upper east region of Ghana. BMC Womens Health. 2019;19(1):1\u20135.","journal-title":"BMC Womens Health"},{"issue":"6","key":"17668_CR14","first-page":"686","volume":"55","author":"G Adjapong","year":"2017","unstructured":"Adjapong G, Hale M, Garrill A. A comparative investigation of azole susceptibility in Candida isolates from vulvovaginal candidiasis and recurrent vulvovaginal candidiasis patients in Ghana. Med Mycol. 2017;55(6):686\u20139.","journal-title":"Med Mycol"},{"issue":"2","key":"17668_CR15","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/epirev\/mxf004","volume":"24","author":"J Martino","year":"2002","unstructured":"Martino J, Vermund S. Vaginal douching: evidence for risks or benefits to women\u2019s Health. Epidemiol Rev. 2002;24(2):109\u201324.","journal-title":"Epidemiol Rev"},{"issue":"2","key":"17668_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.mycmed.2019.04.002","volume":"29","author":"V Djohan","year":"2019","unstructured":"Djohan V, Angora KE, Vanga-Bosson AH, Konat\u00e9 A, Kassi KF, Kiki-Barro PCM, et al. Recurrent vulvo-vaginal candidiasis in Abidjan (C\u00f4te d\u2019Ivoire): Aetiology and associated factors. J Mycol Med. 2019;29(2):127\u201331.","journal-title":"J Mycol Med"},{"key":"17668_CR17","unstructured":"Cochran WG. Sampling Techniques [Internet]. 3rd ed. New York: John Wiley & Sons New York; 1977. 1\u2013100 p. Available from: https:\/\/archive.org\/details\/Cochran1977SamplingTechniques_201703."},{"key":"17668_CR18","unstructured":"Gonz\u00e1lez FU, Guti\u00e9rrez HR, M\u00e9ndez MJD. Recurrent vulvovaginal candidiasis. Rev M\u00e9dica Sinerg. 2021;6(9)."},{"issue":"5","key":"17668_CR19","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/cid\/ciad002","volume":"76","author":"JD Sobel","year":"2023","unstructured":"Sobel JD. New antifungals for vulvovaginal candidiasis: what is their olre? Clin Infect Dis. 2023;76(5):783\u20135.","journal-title":"Clin Infect Dis"},{"key":"17668_CR20","doi-asserted-by":"crossref","unstructured":"Farr A, Effendy I, Tirri BF, Hof H, Mayser P, Petricevic L, et al. Vulvovaginal candidosis (excluding mucocutaneous candidosis): Guideline of the German (DGGG), Austrian (OEGGG) and Swiss (SGGG) Society of Gynecology and Obstetrics. Geburtshilfe Frauenheilkd. 2021;81(4):398\u2013421.","DOI":"10.1055\/a-1345-8793"},{"key":"17668_CR21","doi-asserted-by":"crossref","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al. Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis. 2015;62(4):e1\u201350.","DOI":"10.1093\/cid\/civ933"},{"key":"17668_CR22","doi-asserted-by":"crossref","unstructured":"Sherrard J, Wilson J, Donders G, Mendling W, Jensen JS. 2018 European (IUSTI\/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organization (WHO) guideline on the management of vaginal discharge. Int J STD AIDS. 2018;29(13):1258\u201372.","DOI":"10.1177\/0956462418785451"},{"issue":"3","key":"17668_CR23","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/LGT.0b013e318273e8cf","volume":"17","author":"B Foxman","year":"2013","unstructured":"Foxman B, Muraglia R, Dietz JP, Sobel JD, Wagner J. Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey. J Low Genit Tract Dis. 2013;17(3):340\u20135.","journal-title":"J Low Genit Tract Dis"},{"key":"17668_CR24","doi-asserted-by":"publisher","unstructured":"Blostein F, Mph EL, Wagner J, Foxman B. Recurrent vulvovaginal candidiasis. Ann Epidemiol [Internet]. 2017;27(9):575\u2013582.e3. https:\/\/doi.org\/10.1016\/j.annepidem.2017.08.010.","DOI":"10.1016\/j.annepidem.2017.08.010"},{"key":"17668_CR25","doi-asserted-by":"publisher","unstructured":"Benedict K, Singleton AL, Jackson BR, Molinari NAM. Survey of incidence, lifetime prevalence, and treatment of self-reported vulvovaginal candidiasis, United States, 2020. BMC Womens Health [Internet]. 2022;22(1):1\u20139. https:\/\/doi.org\/10.1186\/s12905-022-01741-x.","DOI":"10.1186\/s12905-022-01741-x"},{"issue":"2","key":"17668_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1083-3188(01)00148-6","volume":"15","author":"MK Oh","year":"2002","unstructured":"Oh MK, Merchant JS, Brown P. Douching behavior in high-risk adolescents: what do they use, when and why do they douche? J Pediatr Adolesc Gynecol. 2002;15(2):83\u20138.","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"17668_CR27","first-page":"2009","volume":"63","author":"S Suwanrattanadech","year":"2011","unstructured":"Suwanrattanadech S, Lertbunnaphong T, Boriboonhirunsarn D. Use of feminine hygiene products in Thai women. Siriraj Med J. 2011;63(4):2009\u201312.","journal-title":"Siriraj Med J"},{"key":"17668_CR28","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1089\/jwh.2010.2281","volume":"20","author":"T Hull","year":"2011","unstructured":"Hull T, Hilber AM, Chersich MF, Bagnol B, Prohmmo A, Smit JA, et al. Prevalence, motivations, and adverse effects of vaginal practices in Africa and Asia: findings from a multicountry household survey. J Women\u2019s Health. 2011;20:1097\u2013109.","journal-title":"J Women\u2019s Health"},{"issue":"2","key":"17668_CR29","doi-asserted-by":"publisher","first-page":"127","DOI":"10.29328\/journal.cjog.1001034","volume":"2","author":"W Yang","year":"2019","unstructured":"Yang W, Nie Y, Wang S, Wang H, Zhao E, Dou N. Previous antibiotic treatment as a risk factor for recurrent vulvovaginal candidiasis. Clin J Obstet Gynecol. 2019;2(2):127\u201332.","journal-title":"Clin J Obstet Gynecol"},{"key":"17668_CR30","doi-asserted-by":"publisher","unstructured":"Daher A, Albaini O, Siff L, Farah S, Jallad K. Intimate hygiene practices and reproductive tract infections: A systematic review. Gynecol Obstet Clin Med [Internet]. 2022;2(3):129\u201335. https:\/\/doi.org\/10.1016\/j.gocm.2022.06.001.","DOI":"10.1016\/j.gocm.2022.06.001"},{"issue":"2","key":"17668_CR31","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/01.aids.0000196165.48518.7b","volume":"20","author":"RS McClelland","year":"2006","unstructured":"McClelland RS, Lavreys L, Hassan WM, Mandaliya K, Ndinya-Achola JO, Baeten JM. Vaginal washing and increased risk of HIV-1 acquisition among African women: a 10-year prospective study. AIDS. 2006;20(2):269\u201373.","journal-title":"AIDS"},{"key":"17668_CR32","doi-asserted-by":"crossref","unstructured":"Nicole W. A question for women\u2019s health:chemicals in feminine hygiene products and personal lubricants. Environ Heal Perspect. 2014;122(3).","DOI":"10.1289\/ehp.122-A70"},{"key":"17668_CR33","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-319-31248-4_6","volume":"902","author":"W Medling","year":"2016","unstructured":"Medling W. Vaginal microbiota. Adv Exp Med Biol. 2016;902:83\u201393.","journal-title":"Adv Exp Med Biol"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-17668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-17668-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-17668-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T12:03:50Z","timestamp":1704456230000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-17668-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,5]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["17668"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-17668-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,5]]},"assertion":[{"value":"29 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"<i>Ethical approval<\/i> Ethical clearance was obtained from the Ghana Institute of Management and Public Administration (GIMPA). Official letters from the health administration of the study sites were obtained granting permission for data collection to be undertaken.<i>Consent to participate<\/i>The participants were informed about the study\u2019s objectives, and valid and written informed consent was obtained directly from participants and legal guardians of those below 18 years before the data collection could begin. The respondents had the right to refuse, withdraw, or terminate at any point without giving any reason. The information provided by the respondents was treated with the highest degree of confidentiality.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"100"}}